Tremeau Pharmaceuticals will be exhibiting at the Hemostasis & Thrombosis Research Society (HTRS) Scientific Symposium on May 10-11 in New Orleans, seeking potential investigators for a pivotal phase III study.

Please stop by and visit booth T16 to learn about our upcoming  trial for TRM-201 (rofecoxib) for the treatment of Hemophilic Arthropathy, and to discuss whether your clinic might qualify as a trial site.